Education
About Us
Working with TipRanks
Follow Us
MicroPort NeuroTech Limited (HK:2172)
:2172
Experimental Device A, A Self-Expanding Rapamycin Target-Eluting Stent (Microport Neurotech, Shanghai, China), Experimental Device B, A Balloon-Expandable Rapamycin Target-Eluting Stent (Microport Neurotech, Shanghai, China), Apollo® Intracranial Artery Stent System, A Balloon-Expandable Bare-Metal Stent (Microport Neurotech, Shanghai, China),
Intracranial Arteriosclerosis
Phase III
Not Yet Recruiting
A Randomized Trial of the Rapamycin Target Eluting Stent for the Treatment of Symptomatic Cerebral Artery Atherosclerotic Disease（TARGET-DREAM）
Mar 27, 2025
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does MicroPort NeuroTech Limited (2172) have in its pipeline
2172 is currently developing the following drugs: Experimental Device A, A Self-Expanding Rapamycin Target-Eluting Stent (Microport Neurotech, Shanghai, China), Experimental Device B, A Balloon-Expandable Rapamycin Target-Eluting Stent (Microport Neurotech, Shanghai, China), Apollo® Intracranial Artery Stent System, A Balloon-Expandable Bare-Metal Stent (Microport Neurotech, Shanghai, China),. These drug candidates are in various stages of clinical development as the company works toward FDA approval.